Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 89 for “"Group A Streptococcus"”.
-
Development of a Glycoconjugate Vaccine Against Group A Streptococcus (GAS)
Group A Streptococcus (GAS) is responsible for superficial infections, systemic disease, and autoimmune complications globally. Despite extensive research no commercial GAS vaccine currently exists. The highly abundant, conserved surface exposed Lancefield Group A Carbohydrate (GAC) is of interest …
-
Functional Domains in the Multigene Regulator of the Group A Streptococcus
The group A streptococcus (GAS) is a human pathogen capable of causing a broad range of symptoms from mild erythema to severe tissue destruction. The multigene regulator of the GAS, or Mga, has been shown to bind DNA and activate transcription of virulence genes implicated in colonization and …
-
An Analysis of Serotype-Specific Virulence in the Group A Streptococcus
Group A Streptococcus (GAS or Streptococcus pyogenes) is a Gram-positive coccus responsible for a wide range of human diseases, from mild infections such as pharyngitis/strep throat to invasive infections such as puerperal sepsis and necrotizing fasciitis. GAS results in nearly 500,000 annual …
-
Adhesion and internalization of group A streptococcus isolates found in Hawaii
M/emm typing was performed for clinical isolates of GAS from Hawaiʻi. Of the 54 M/emm types found, 41% belonged to recently validated or newer sequence types. M/emm 4, 12, 28 and 1 were most frequently found throat associated. M/emm 85 and 63 were found frequently skin associated and emm 66 and 81 …
-
Molecular Mechanisms Controlling Virulence Factor Gene Expression in the Group A Streptococcus
The group A Streptococcus (GAS or Streptococcus pyogenes) has a remarkable ability to cause a large variety of human diseases ranging from mild illnesses to serious infections. GAS is the most common cause of bacterial pharyngitis (>600 million infections annually) and a leading cause of …
-
Serotype-Specifc Virulence Factor Expression and Regulation in the Group A Streptococcus
The group A Streptococcus (GAS) is a Gram-positive human obligate pathogen, and is capable of causing perhaps the most diverse array of clinical manifestations of any known pathogen. Disease states range from mild and typically self-limiting phayngeal infections (the canonical "strep throat") …
-
RATIONAL DESIGN AND SYNTHESIS OF A GLYCOCONJUGATE VACCINE AGAINST GROUP A STREPTOCOCCUS
… reduce reaction time and use of protective groups during synthetic steps and favor oligosaccharides production at large scale. In addition, nanoparticles have been recently proposed as potential multivalent delivery systems also for carbohydrate-based vaccines. Gold nanoparticles (AuNPs) …
-
Defining the Role of SpxA1 and SpxA2 in Group A Streptococcus (GAS)
Group A Streptococcus (GAS) is a human-restricted pathogen whose global incidence has surged in the post-COVID era. The ability of GAS to shift from a colonizing to invasive phenotype depends on coordinated virulence gene regulation in response to host-imposed stressors. The paralogous global …
-
Effect of Superantigen on Detecting Group A Streptococcus Specific T cell responses
Streptococcus pyogenes, also known as Group A Streptococcus (GAS), causes a wide variety of clinical manifestations. An effective GAS vaccine would significantly reduce morbidity and mortality, however, development has been restricted by GAS serotype/strain diversity. As GAS is predominantly …
-
Comprehensive Investigation into the Molecular Mechanisms Driving the Emergence of emm4 Group A Streptococcus
… Mechanisms Driving the Emergence of emm4 Group A Streptococcus Chioma Modeline Odo, M.S. Advisory Professor: Samuel A. Shelburne, MD, Ph.D. The major gram-positive bacterium group A Streptococcus (GAS) is a model organism for studying microbial epidemics as it is well known to cause …
-
Role of rocA Polymorphisms on Virulence and Pathogenesis of Serotype M28 Group A Streptococcus
Group A Streptococcus (Streptococcus pyogenes, GAS) is a human-specific pathogen that causes a wide range of diseases and significant morbidity and mortality worldwide. Despite over a century of research, no licensed human vaccine exists to protect against GAS infection, which may be due, in part, …
-
Streptococcal collagen-like protein 1, Scl1, modulates group a Streptococcus adhesion, biofilm formation and virulence
… streptococcal collagen-like protein 1, scl1, of group A Streptococcus (GAS) binds extracellular matrix components (ECM), cellular fibronectin and laminin, via the surface-exposed globular domain. GAS strains express scl1 and form biofilm in vitro, except for M3-type strains that are particularly …
-
ROLE OF THE PHOSPHOENOLPYRUVATE: CARBOHYDRATE PHOSPHOTRANSFERASE SYSTEM IN THE VIRULENCE OF THE GROUP A STREPTOCOCCUS
Group A Streptococcus (GAS) is a fastidious microorganism that has adapted to a variety of niches in the human body by sensing its surroundings and modifying its metabolism to elicit a wide array of diseases. The Phosphoenolpyruvate Phosphotransferase System (PTS) is a primary mechanism by which …
-
THE IMPORTANCE OF NUTRIENT ADAPTATION AND UPTAKE BY GROUP A STREPTOCOCCUS FOR ITS GROWTH AND INFECTION
A major human-specific pathogen, Streptococcus pyogenes (Group A Streptococcus, GAS) causes a wide range of infections, from superficial to life-threatening diseases throughout different host niches. Thus, it is necessary to gain a better understanding of how GAS is able to overcome …
Page 1 of 5